Cambridge biotech Enumeral files for bankruptcy, sells cancer drugs

The nine-year-old company generated some buzz in 2014 by signing a partnership deal with Merck, but never tested its experimental treatments in a human trial.

Source: bizjournals.com Health Care News Headlines - February 6, 2018 Category: Health Management Authors: Max Stendahl Source Type: news